Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares

CANF XASE

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

6.7M

Short interest (May 15)

5.4%

Net Short (Jun 03 ): 0.0%

Borrow Fee

141.19%

↓ 32.6%

Available Shares

70K

↑ 34.5%

Price Chart

Company Overview

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Company Info

Exchange: XASE

CIK: 0001536196

Asset Type: ADRC

Market Data

Market Cap: $6,663,321

Employees: 5

Status: Active

Short Interest

Current Borrow Fee 141.19%

Range: 141.19% - 189.58%

Available Shares 70K

Range: 35K - 80K

Recent Changes

Fee Change: ↑ 10.6%

Available Change: ↑ 16.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime